Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

FRANCE: Sanofi Joins with TB Alliance to Find New Treatments Against Tuberculosis


RTT News (09.20.12) Aids Weekly Plus

The French pharmaceutical company, Sanofi, recently announced an agreement with the Global Alliance for TB Drug Development (TB Alliance) to collaborate on the discovery and development of new TB drugs. Both companies will work to develop novel compounds in Sanofi’s library that have shown promise against the TB bacterium. The agreement includes in-depth research of lead compounds based upon identified chemical derivatives of natural products and chemical optimization of other series of compounds that have been identified as hits in high-throughput screening. Sanofi discovered rifampicin, one of the first-line antituberculosis drugs, in the early 1960s.


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in September 21, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.